e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
REGENXBIO Inc. - Common Stock
(NQ:
RGNX
)
7.990
+0.470 (+6.25%)
Streaming Delayed Price
Updated: 2:24 PM EDT, May 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about REGENXBIO Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 26, 2025
Via
Benzinga
Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial
March 19, 2025
Regenxbio's RGX-202 gene therapy shows promising results in Duchenne muscular dystrophy, with high microdystrophin levels and a well-tolerated safety profile.
Via
Benzinga
Signet Jewelers, BGM Group, StoneCo, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
March 19, 2025
Via
Benzinga
Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Friday
March 14, 2025
Via
Benzinga
A Glimpse Into The Expert Outlook On Regenxbio Through 7 Analysts
February 11, 2025
Via
Benzinga
Regenxbio Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
January 15, 2025
Via
Benzinga
Earnings Scheduled For May 12, 2025
Today 4:32 EDT
Via
Benzinga
What to Expect from Regenxbio's Earnings
May 09, 2025
Via
Benzinga
The One-Minute Market Report - Saturday, April 26
April 26, 2025
In this brief market report, we will take a look at the various asset classes, sectors, equity categories, ETFs, and stocks that moved the market higher, as well as the market segments that defied the...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
April 21, 2025
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
Product Safety
What's going on in today's after hours session
March 31, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Where Regenxbio Stands With Analysts
December 11, 2024
Via
Benzinga
5 Analysts Have This To Say About Regenxbio
November 15, 2024
Via
Benzinga
What 4 Analyst Ratings Have To Say About Regenxbio
October 10, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Regenxbio Through 5 Analysts
March 14, 2025
Via
Benzinga
Earnings Scheduled For March 13, 2025
March 13, 2025
Via
Benzinga
Assessing Regenxbio: Insights From 5 Financial Analysts
September 04, 2024
Via
Benzinga
Where Regenxbio Stands With Analysts
August 05, 2024
Via
Benzinga
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
February 11, 2025
Regenxbio's gene therapy faces market challenges as Goldman Sachs lowers its rating and price target, citing competition and declining appeal in retinal diseases.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 14, 2025
Via
Benzinga
Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
January 14, 2025
Via
Benzinga
Workday, Apollo Global To Join S&P 500 Index In Quarterly Balance
December 06, 2024
They'll join the index before the open on Dec. 23 as part of a quarterly rebalance.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
What's Going On With REGENXBIO Shares Monday?
November 18, 2024
REGENXBIO stock is trading higher on Monday after the company reached a critical point in its trial for Duchenne gene therapy.
Via
Benzinga
Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday
November 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 06, 2024
Via
Benzinga
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
September 04, 2024
From
FN Media Group LLC
Via
GlobeNewswire
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks.
Via
InvestorPlace
Why Is Clearside Biomedical Stock Gaining Today?
June 25, 2024
Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS...
Via
Benzinga
7 Biotech Stocks to Buy on the Dip: June 2024
June 24, 2024
With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
wpDiscuz
Insert
